Elite in Arthritis

Jurgen Wollenhaupt

Friedrichsberger Str. 60, 
Eilbek, HH, DE 
Elite in Arthritis
Friedrichsberger Str. 60, 
Eilbek, HH, DE 
OverviewLocationsClinical Research

Overview

Jurgen Wollenhaupt practices in Eilbek, Germany. Wollenhaupt is rated as an Elite expert by MediFind in the treatment of Arthritis. Their top areas of expertise are Arthritis, Psoriatic Arthritis, Rheumatoid Arthritis (RA), and Psoriasis.

Their clinical research consists of co-authoring 76 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 61 articles and participated in 3 clinical trials in the study of Arthritis.

Locations

Friedrichsberger Str. 60, Eilbek, HH 22081, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Randomized, Double-Blind, Parallel-Group, Placebo- and Active-Controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Methotrexate Therapy
A Randomized, Double-Blind, Parallel-Group, Placebo- and Active-Controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Methotrexate Therapy
Enrollment Status: Completed
Publish Date: September 21, 2023
Intervention Type: Drug
Study Phase: Phase 3
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Study to Evaluate Safety and Clinical Efficacy of Two Different Doses of F8IL10 (Dekavil) Administered Subcutaneously to Patients With Active Rheumatoid Arthritis Receiving Methotrexate.
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Study to Evaluate Safety and Clinical Efficacy of Two Different Doses of F8IL10 (Dekavil) Administered Subcutaneously to Patients With Active Rheumatoid Arthritis Receiving Methotrexate.
Enrollment Status: Terminated
Publish Date: June 12, 2023
Intervention Type: Drug
Study Drugs: F8IL10, Methotrexate
Study Phase: Phase 2
A Phase II, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy and Safety Study of Two Dose Regimens of CC-10004 in Subjects With Active Psoriatic Arthritis
A Phase II, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy and Safety Study of Two Dose Regimens of CC-10004 in Subjects With Active Psoriatic Arthritis
Enrollment Status: Completed
Publish Date: June 19, 2020
Intervention Type: Drug
Study Phase: Phase 2
View 2 Less Clinical Trials

76 Total Publications

Criteria for the authorisation of specialty training for competence in internal medicine and rheumatology-a position paper of the German Society for Rheumatology and Clinical Immunology.
Criteria for the authorisation of specialty training for competence in internal medicine and rheumatology-a position paper of the German Society for Rheumatology and Clinical Immunology.
Journal: Zeitschrift fur Rheumatologie
Published: January 08, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Wollenhaupt's expertise for a condition
ConditionClose
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile